Hong Kong Traditional Chinese Medicine & Physiotherapy Company Mayan Hall (MCTA.US) IPO at $4 per share soared 75% on the first day of listing.
Hong Kong Traditional Chinese Medicine Healthcare Company Meiyantang landed on the Nasdaq on Tuesday, with an initial public offering (IPO) priced at $4 per share.
Hong Kong Traditional Chinese Medicine Therapy Company MCTA.US, also known as Beauty Lab, made its debut on the Nasdaq on Tuesday with an initial public offering (IPO) priced at $4 per share, at the lower end of the previously announced $4-6 price range. The company issued 1.6 million shares in its IPO, raising $6 million. The stock surged 75.0% on its first day of trading, closing at $7.0
Based in Hong Kong, Beauty Lab provides therapies and products inspired by Traditional Chinese Medicine (TCM). The company currently operates 4 health centers in Hong Kong under the brand "Beauty Lab," offering beauty, health, postpartum services and products. The company also offers personalized TCM therapies for men. Data shows that for the six months ending September 30, 2024, Beauty Lab had revenue of $2.96 million, compared to $2.61 million in the same period last year, with respective net profits of $470,000 and $380,000.
Related Articles

US Stock Market Move | Net Plastic Technology (NPT.US) debuts on the US stock market, triggering a circuit breaker after the opening.

US Stock Market Move | Chip stocks generally fell, with Intel Corporation (INTC.US) falling over 4%.

US Stock Market Move | AI software stocks are falling, Palantir (PLTR.US) plunges over 6%.
US Stock Market Move | Net Plastic Technology (NPT.US) debuts on the US stock market, triggering a circuit breaker after the opening.

US Stock Market Move | Chip stocks generally fell, with Intel Corporation (INTC.US) falling over 4%.

US Stock Market Move | AI software stocks are falling, Palantir (PLTR.US) plunges over 6%.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025